Market Overview:
The global nasal antihistamines market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of allergic rhinitis, rising awareness about the benefits of using nasal antihistamines, and growing demand for over-the-counter (OTC) drugs. In addition, technological advancements in the field of nasal antihistamines are also contributing to the growth of this market. The global nasal antihistamines market is segmented on the basis of type into sprays, drops, and gels. The sprays segment is expected to account for a major share of the global nasal antihistamines market in 2018 owing to their easy availability and low cost as compared to other types of nasal antihistamines products. On the basis of application, hospitals accounted for a major share of the global nasals antihistamine market in 2017 due to increased use by patients suffering from chronic allergies or sinus infections. However, clinics are projectedto register highest CAGR during forecast period owingto increasing numberof outpatient visitsfor treatmentof allergiesand asthma symptoms .
Product Definition:
Nasal Antihistamines are a type of medication that is used to treat the symptoms of allergies. They work by blocking the effects of histamine, which is a chemical that is released when the body becomes inflamed. Nasal Antihistamines can help reduce inflammation and congestion in the nose and sinuses.
Sprays:
Sprays are usually a combination of 2 or more drugs, which are used for the treatment of allergies and colds. They work by blocking the action of histamine in the nose. Some people who have very sensitive nasal passages may experience an allergic reaction after using sprays, this can lead to itching, redness and swelling in the nose area as well as other parts of the body.
Drops:
Nasal antihistamines are used for the treatment of allergies caused due to dust, mold, animal dander, and various other environmental factors. The most common symptoms associated with these conditions are itchy eyes/skin, runny nose/headache and fatigue. Antihistamines act by binding to histamine receptors present on nerve cells in the brain and nasal passages thereby blocking the transmission of histamine.
Application Insights:
The pharmacy application segment led the global nasal antihistamines market in 2017. This was attributed to growing awareness about health and wellness among individuals, coupled with rising incidences of allergy-related disorders. According to a study published by Allergy UK, approximately 40% of patients have some type of allergic rhinitis. Nasal sprays are one of the most commonly used drugs for treating allergic rhinitis as they are easy to use and can be applied directly into the nose without the need for further dilution or preparation.
drops also proved effective against nasal allergies in clinical trials but have not been approved by regulatory authorities for widespread usage due largely to concerns regarding potential side effects associated with them (e.g., sedation).
Regional Analysis:
North America dominated the global market in 2017 owing to the rising incidence of upper respiratory infections and increasing awareness about nasal allergy treatments. The region is expected to maintain its dominance over the forecast period due to factors such as favorable reimbursement policies, high healthcare expenditure, and well-established healthcare infrastructure. Moreover, growing demand for advanced diagnostic techniques for allergic disorders is anticipated to fuel regional growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing with rapid economic development in emerging countries such as India and China. Furthermore, an increase in international travel has increased exposure towards common colds across this region which has further boosted product demand leading to a significant share of overall revenue generated by this sector globally (2017).
Growth Factors:
- Increasing prevalence of allergic rhinitis and sinusitis: The global nasal antihistamines market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing prevalence of allergic rhinitis and sinusitis. According to a study by American Academy of Allergy, Asthma & Immunology (AAAAI), approximately 50 million people in the U.S are affected by allergies each year and this number is expected to rise in the coming years.
- Growing awareness about benefits offered by nasal antihistamines: There is growing awareness among consumers about the benefits offered by nasal antihistamines such as prevention or relief from symptoms associated with allergies, asthma, and colds & flu’s etc. This is likely to boost demand for these products in the coming years.
- Technological advancements in product formulation: Nasal antihistamines manufacturers are focusing on developing innovative products that offer better efficacy and compliance than traditional therapies options available in the market currently .This is likely to fuel growth of this market during forecast period . For instance , In July 2017 , Merck announced launch of its new product – Rhinocort Aqua Nasal Spray which offers long-term relief from allergy symptoms with once-daily dosing .
Scope Of The Report
Report Attributes
Report Details
Report Title
Nasal Antihistamines Market Research Report
By Type
Sprays, Drops, Gels
By Application
Hospitals, Clinics, Pharmacy, Homecare Setting
By Companies
Bayer Healthcare, Novartis, Merck& Co inc, Zicam LLC, F.Hoffman La Roche, Ache Laboratories, GlaxoSmithKline, ARIUS FORMULATIONS PVT LTD, Renatus, Aurena, Cipla, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Nasal Antihistamines Market Report Segments:
The global Nasal Antihistamines market is segmented on the basis of:
Types
Sprays, Drops, Gels
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Pharmacy, Homecare Setting
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Healthcare
- Novartis
- Merck& Co inc
- Zicam LLC
- F.Hoffman La Roche
- Ache Laboratories
- GlaxoSmithKline
- ARIUS FORMULATIONS PVT LTD
- Renatus
- Aurena
- Cipla
- Allergan
Highlights of The Nasal Antihistamines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sprays
- Drops
- Gels
- By Application:
- Hospitals
- Clinics
- Pharmacy
- Homecare Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nasal Antihistamines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nasal antihistamines are medications that block the histamine response in the nose. This can help to reduce symptoms of allergies, such as sneezing, runny nose, and itchy eyes.
Some of the major players in the nasal antihistamines market are Bayer Healthcare, Novartis, Merck& Co inc, Zicam LLC, F.Hoffman La Roche, Ache Laboratories, GlaxoSmithKline, ARIUS FORMULATIONS PVT LTD, Renatus, Aurena, Cipla, Allergan.
The nasal antihistamines market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nasal Antihistamines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nasal Antihistamines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nasal Antihistamines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nasal Antihistamines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nasal Antihistamines Market Size & Forecast, 2018-2028
4.5.1 Nasal Antihistamines Market Size and Y-o-Y Growth
4.5.2 Nasal Antihistamines Market Absolute $ Opportunity
Chapter 5 Global Nasal Antihistamines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nasal Antihistamines Market Size Forecast by Type
5.2.1 Sprays
5.2.2 Drops
5.2.3 Gels
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nasal Antihistamines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nasal Antihistamines Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Pharmacy
6.2.4 Homecare Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nasal Antihistamines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nasal Antihistamines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nasal Antihistamines Analysis and Forecast
9.1 Introduction
9.2 North America Nasal Antihistamines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nasal Antihistamines Market Size Forecast by Type
9.6.1 Sprays
9.6.2 Drops
9.6.3 Gels
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nasal Antihistamines Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Pharmacy
9.10.4 Homecare Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nasal Antihistamines Analysis and Forecast
10.1 Introduction
10.2 Europe Nasal Antihistamines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nasal Antihistamines Market Size Forecast by Type
10.6.1 Sprays
10.6.2 Drops
10.6.3 Gels
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nasal Antihistamines Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Pharmacy
10.10.4 Homecare Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nasal Antihistamines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nasal Antihistamines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nasal Antihistamines Market Size Forecast by Type
11.6.1 Sprays
11.6.2 Drops
11.6.3 Gels
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nasal Antihistamines Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Pharmacy
11.10.4 Homecare Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nasal Antihistamines Analysis and Forecast
12.1 Introduction
12.2 Latin America Nasal Antihistamines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nasal Antihistamines Market Size Forecast by Type
12.6.1 Sprays
12.6.2 Drops
12.6.3 Gels
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nasal Antihistamines Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Pharmacy
12.10.4 Homecare Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nasal Antihistamines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nasal Antihistamines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nasal Antihistamines Market Size Forecast by Type
13.6.1 Sprays
13.6.2 Drops
13.6.3 Gels
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nasal Antihistamines Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Pharmacy
13.10.4 Homecare Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nasal Antihistamines Market: Competitive Dashboard
14.2 Global Nasal Antihistamines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Healthcare
14.3.2 Novartis
14.3.3 Merck& Co inc
14.3.4 Zicam LLC
14.3.5 F.Hoffman La Roche
14.3.6 Ache Laboratories
14.3.7 GlaxoSmithKline
14.3.8 ARIUS FORMULATIONS PVT LTD
14.3.9 Renatus
14.3.10 Aurena
14.3.11 Cipla
14.3.12 Allergan
